Showing results (1981-1990 of 2,026) with videos related to
Sort By:
Pageof 203
Brain : a Journal of Neurology|May 29, 2021
Impact of autism genetic risk on brain connectivity: a mechanism for the female protective effectKatherine E Lawrence, Leanna M Hernandez, Emily Fuster, et al.Neuro-Oncology Advances|October 16, 2023
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patientsM J Webb, Bryan J Neth, Lauren M Webb, et al.Frontiers in Integrative Neuroscience|April 30, 2020
The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker QualificationJames C McPartland, Raphael A Bernier, Shafali S Jeste, et al.BMC Infectious Diseases|May 26, 2026
Beyond traditional tetracyclines: a real-world evaluation of effectiveness and safety of omadacycline therapy for complex bacterial infectionsMohammed Al Musawa, Amer El Ghali, Taylor Morrisette, et al.Scientific Reports|October 23, 2015
Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injuryA D B Vliegenthart, J M Shaffer, J I Clarke, et al.Scientific Reports|December 1, 2015
Red clover (Trifolium pratense L.) draft genome provides a platform for trait improvementJose J De Vega, Sarah Ayling, Matthew Hegarty, et al.The Lancet. Gastroenterology & Hepatology|September 1, 2020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry studyGwilym J Webb, Thomas Marjot, Jonathan A Cook, et al.Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.Stem Cell Research & Therapy|February 26, 2014
Neurovascular unit on a chip: implications for translational applicationsDonald J Alcendor, Frank E Block, David E Cliffel, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 18, 2024
Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related DecisionsWendy L St Peter, Andrew S Bzowyckyj, Tracy Anderson-Haag, et al.Pageof 203